Charles River Laboratories International, Inc. (CRL) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 9.2% on average (either way), rising 6 times and falling 6. EPS beat estimates 12 of 12 times; revenue 12 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | 3.09 | 2.97 | +4.0% | 982.7M | 960.4M | -11.0% |
| Q2 FY2026 | 2026-08-05 | 3.02 | 2.74 | +10.2% | 1.00B | 977.2M | +13.4% |
| Q1 FY2026 | 2026-05-07 | 2.06 | 1.96 | +5.1% | 995.8M | 977.5M | -2.3% |
| Q4 FY2025 | 2026-02-18 | 2.39 | 2.33 | +2.6% | 994.2M | 987.0M | +3.6% |
| Q3 FY2025 | 2025-11-05 | 2.43 | 2.32 | +4.7% | 1.00B | 987.2M | -3.9% |
| Q2 FY2025 | 2025-08-06 | 3.12 | 2.50 | +24.8% | 1.03B | 968.9M | -10.6% |
| Q1 FY2025 | 2025-05-07 | 2.34 | 2.06 | +13.6% | 984.2M | 958.8M | +22.5% |
| Q4 FY2024 | 2025-02-19 | 2.66 | 2.50 | +6.4% | 1.00B | 948.2M | +5.1% |